Literature DB >> 25378656

The rs738409 (I148M) variant of the PNPLA3 gene and cirrhosis: a meta-analysis.

Jian-Hua Shen1, Yi-Ling Li1, Dan Li1, Ning-Ning Wang1, Lei Jing1, Yu-Hong Huang1.   

Abstract

The human patatin-like phospholipase domain-containing-3 (PNPLA3) gene rs738409 C>G polymorphism is associated with several types of liver disease. The aim of this meta-analysis was to assess the risk of cirrhosis on the basis of rs738409 allele frequency and genotype. Medline, the Cochrane Library, EMBASE, and Google Scholar were searched for prospective and retrospective studies assessing the effect of the rs738409 polymorphism on liver cirrhosis. Seven studies, involving 2,023 patients with cirrhosis, were included. The G allele was associated with a significantly increased risk of cirrhosis versus the C allele [pooled odds ratio (OR) = 1.86, 95% confidence interval (CI) = 1.64-2.12, Z = 9.55, P < 0.001]. Both the GC and GG genotypes were associated with a significantly increased risk of cirrhosis versus the CC genotype (GC vs. CC: pooled OR = 1.73, 95% CI = 1.51-1.98, Z = 7.86, P < 0.001; GG vs. CC: pooled OR = 3.41, 95% CI = 2.77-4.18, Z = 11.65, P < 0.001). There was no evidence of publication bias. Our findings suggest that patients at risk for liver cirrhosis may benefit from PNPLA3 genotyping and thus more intensive monitoring if the rs738409 C>G polymorphism is identified.
Copyright © 2015 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  cirrhosis; patatin-like phospholipase domain-containing-3 gene; polymorphism

Mesh:

Substances:

Year:  2014        PMID: 25378656      PMCID: PMC4274064          DOI: 10.1194/jlr.M048777

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  47 in total

1.  Characterization of the human patatin-like phospholipase family.

Authors:  Paul A Wilson; Scott D Gardner; Natalie M Lambie; Stephane A Commans; Daniel J Crowther
Journal:  J Lipid Res       Date:  2006-06-25       Impact factor: 5.922

Review 2.  The role of genetic polymorphisms in alcoholic liver disease.

Authors:  Felix Stickel; Christoph H Osterreicher
Journal:  Alcohol Alcohol       Date:  2006-02-21       Impact factor: 2.826

3.  Detection of hepatitis C virus antibodies and hepatitis C virus RNA in patients with alcoholic liver disease.

Authors:  S Nishiguchi; T Kuroki; T Yabusako; S Seki; K Kobayashi; T Monna; S Otani; M Sakurai; T Shikata; S Yamamoto
Journal:  Hepatology       Date:  1991-12       Impact factor: 17.425

4.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

5.  Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study.

Authors:  U Becker; A Deis; T I Sørensen; M Grønbaek; K Borch-Johnsen; C F Müller; P Schnohr; G Jensen
Journal:  Hepatology       Date:  1996-05       Impact factor: 17.425

6.  Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features.

Authors:  P Mathurin; F Beuzin; A Louvet; N Carrié-Ganne; A Balian; J C Trinchet; D Dalsoglio; S Prevot; S Naveau
Journal:  Aliment Pharmacol Ther       Date:  2007-05-01       Impact factor: 8.171

7.  Excess weight risk factor for alcoholic liver disease.

Authors:  S Naveau; V Giraud; E Borotto; A Aubert; F Capron; J C Chaput
Journal:  Hepatology       Date:  1997-01       Impact factor: 17.425

8.  Risk factors of fibrosis in alcohol-induced liver disease.

Authors:  Bruno Raynard; Axel Balian; David Fallik; Frédérique Capron; Pierre Bedossa; Jean-Claude Chaput; Sylvie Naveau
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

9.  Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver.

Authors:  M R Teli; C P Day; A D Burt; M K Bennett; O F James
Journal:  Lancet       Date:  1995-10-14       Impact factor: 79.321

Review 10.  The epidemiology of alcoholic liver disease.

Authors:  Robert E Mann; Reginald G Smart; Richard Govoni
Journal:  Alcohol Res Health       Date:  2003
View more
  16 in total

Review 1.  Is That Possible to Stop or Cease the NASH to Turn into HCC?

Authors:  Ahmet Uygun
Journal:  J Gastrointest Cancer       Date:  2017-09

Review 2.  Genetic factors that affect nonalcoholic fatty liver disease: A systematic clinical review.

Authors:  Tyler J Severson; Siddesh Besur; Herbert L Bonkovsky
Journal:  World J Gastroenterol       Date:  2016-08-07       Impact factor: 5.742

3.  Emerging risk factors for nonalcoholic fatty liver disease associated hepatocellular carcinoma.

Authors:  Jihane N Benhammou; Jonathan Lin; Shehnaz K Hussain; Mohamed El-Kabany
Journal:  Hepatoma Res       Date:  2020-06-18

4.  A common variant in PNPLA3 is associated with age at diagnosis of NAFLD in patients from a multi-ethnic biobank.

Authors:  Ryan W Walker; Gillian M Belbin; Elena P Sorokin; Tielman Van Vleck; Genevieve L Wojcik; Arden Moscati; Christopher R Gignoux; Judy Cho; Noura S Abul-Husn; Girish Nadkarni; Eimear E Kenny; Ruth J F Loos
Journal:  J Hepatol       Date:  2020-03-05       Impact factor: 25.083

5.  Influence of the PNPLA3 rs738409 Polymorphism on Non-Alcoholic Fatty Liver Disease and Renal Function among Normal Weight Subjects.

Authors:  Kentaro Oniki; Junji Saruwatari; Tomoko Izuka; Ayami Kajiwara; Kazunori Morita; Misaki Sakata; Koji Otake; Yasuhiro Ogata; Kazuko Nakagawa
Journal:  PLoS One       Date:  2015-07-22       Impact factor: 3.240

Review 6.  Definitions of Normal Liver Fat and the Association of Insulin Sensitivity with Acquired and Genetic NAFLD-A Systematic Review.

Authors:  Elina M Petäjä; Hannele Yki-Järvinen
Journal:  Int J Mol Sci       Date:  2016-04-27       Impact factor: 5.923

7.  Duplex High-Resolution Melting Assay for the Simultaneous Genotyping of IL28B rs12979860 and PNPLA3 rs738409 Polymorphisms in Chronic Hepatitis C Patients.

Authors:  Elena L Enache; Anca Sin; Ligia Bancu; Christophe Ramière; Olivier Diaz; Patrice André; Liviu S Enache
Journal:  Int J Mol Sci       Date:  2015-09-14       Impact factor: 5.923

8.  Cirrhosis and Advanced Fibrosis in Hispanics in Texas: The Dominant Contribution of Central Obesity.

Authors:  Jingjing Jiao; Gordon P Watt; MinJae Lee; Mohammad H Rahbar; Kristina P Vatcheva; Jen-Jung Pan; Joseph B McCormick; Susan P Fisher-Hoch; Michael B Fallon; Laura Beretta
Journal:  PLoS One       Date:  2016-03-07       Impact factor: 3.240

Review 9.  PNPLA3 expression and its impact on the liver: current perspectives.

Authors:  Francesca Virginia Bruschi; Matteo Tardelli; Thierry Claudel; Michael Trauner
Journal:  Hepat Med       Date:  2017-11-06

10.  A two gene-based risk score predicts alcoholic cirrhosis development in males with at-risk alcohol consumption.

Authors:  Rosellina Margherita Mancina; Flaminia Ferri; Alessio Farcomeni; Antonio Molinaro; Angela Maffongelli; Monica Mischitelli; Edoardo Poli; Lucia Parlati; Maria Antonella Burza; Adriano De Santis; Fabio Attilia; Claudia Rotondo; Maria Margherita Rando; Maria Luisa Attilia; Mauro Ceccanti; Stefano Ginanni Corradini
Journal:  Appl Clin Genet       Date:  2019-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.